CCCC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - C4 Therapeutics Inc

Watchlist Manager

Watchlist

Price: 3.55 USD -1.11% Market Closed

Market Cap: $392.5m

	C4 Therapeutics Inc NASDAQ:CCCC	US
B	Brookdale Senior Living Inc XBER:B7S	US
	D'Ieteren Group NV XBRU:DIE	BE
R	Rheinmetall AG DUS:RHM	DE
	Isetan Mitsukoshi Holdings Ltd TSE:3099	JP
	NN Group NV AEX:NN	NL

Profitability Summary

C4 Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-327%

Negative 3Y Average Operating Margin

-472%

Operating Margin is Increasing

-902% > -327%

Negative Net Margin

-298%

Negative 3Y Average Net Margin

-446%

Net Margin is Increasing

-873% > -298%

Negative Free Cash Flow Margin

-275%

Negative 3Y Average Free Cash Flow Margin

-355%

Free Cash Flow Margin is Increasing

-718% > -275%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-107%

Declining ROIC

-101% > -116%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.